QQ客服 官方微博 反馈留言

浏览/检索结果: 共18条，第1-10条 帮助 限定条件 专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor 期刊论文 THORACIC CANCER, 2022 作者:  Wang, Wenxian;  Wang, Qian;  Xu, Chunwei;  Li, Ziming;  Song, Zhengbo 收藏  |  浏览/下载：32/0  |  提交时间：2022/12/23 checkpoint inhibitor pneumonitis  Chinese experts consensus  immune checkpoint inhibitor-related adverse effects   Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文 BRITISH JOURNAL OF CANCER, 2022 作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili 收藏  |  浏览/下载：21/0  |  提交时间：2022/12/22 Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 卷号: 15 作者:  Liu, Long;  Yu, Xingxing;  Li, Zhifeng;  He, Xiaohua;  Zha, Jie 收藏  |  浏览/下载：228/0  |  提交时间：2022/12/23 FL  TIME  POD  Immune signature  T cells   Ratiometric co-delivery of hydroxychloroquine and calculated low-dose paclitaxel efficiently suppresses tumor growth in hepatocellular carcinoma mouse models in vivo 期刊论文 NANO TODAY, 2022, 卷号: 44 作者:  Wang, Wenbin;  Sun, Hui;  Gong, Yan;  Liu, Xiangsheng;  Liu, Xiao 收藏  |  浏览/下载：120/0  |  提交时间：2022/12/23 Ratiometric co-delivery  Autophagy  Hepatocellular carcinoma  Chemo-immunotherapy  Hydroxychloroquine  Paclitaxel   A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC). 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40 作者:  Wang, Jing;  Lou, Hanmei;  Cai, Hong-Bing;  Huang, Xin;  Li, Guiling 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23 Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文 CLINICAL CANCER RESEARCH, 2022, 卷号: 28 作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng 收藏  |  浏览/下载：29/0  |  提交时间：2022/05/05 Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review 期刊论文 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Lin, Yuxin;  Zhu, Wei;  Wu, Bingchen;  Lan, Huiyin 收藏  |  浏览/下载：22/0  |  提交时间：2022/05/16 Sarcoid-like reaction  immune checkpoint inhibitor  Toripalimab  PD-1  case report   Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文 LANCET ONCOLOGY, 2022, 卷号: 23 作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng 收藏  |  浏览/下载：104/0  |  提交时间：2022/03/21 Infiltrating T lymphocytes in the tumor microenvironment of small cell lung cancer: a state of knowledge review 期刊论文 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022 作者:  Chen, Yamei;  Jin, Ying;  Hu, Xiao;  Chen, Ming 收藏  |  浏览/下载：36/0  |  提交时间：2022/02/14 Small cell lung cancer  Tumor-infiltrating lymphocyte  T cell  Tumor microenvironment   High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文 BMC CANCER, 2022, 卷号: 22 作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao 收藏  |  浏览/下载：43/0  |  提交时间：2022/02/14 Hodgkin lymphoma  PD-1 inhibitor  PD-L1 inhibitor  PD-L2  Molecular phenotype  Tumor microenvironment